The Effect of Low Intensity Shockwave Therapy for ED in Post Radical Prostatectomy Patients Who Didn't Respond to PDE5i (LI-ESWT)

Rambam Health Care Campus

Status and phase: Completed; Phase 3

Conditions: Erectile Dysfunction

Treatments: Device: LI-ESWT

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01274949

3060 radical

Details and patient eligibility

About

Low Intensity Shock Wave Therapy (LI-ESWT) was shown to have a beneficial effect on ED patients responding to PDE5i's. This study aimed to determine the capability of LI-ESWT to affect patients who underwent radical prostatectomy who did not respond to PDE5 inhibitor therapy.

Full description

We included severe ED patients that underwent radical prostatectomy at least one year previously and failed to respond to PDE5i therapy, who scored 0-2 on the rigidity scale (RS) during PDE5i therapy. Treatment included 2 sessions/week for 3 weeks, repeated after a 3-week no-treatment interval. At each session LI-ESWT was applied on the penile shaft and crus for 3 minutes in 5 different penile anatomical sites (intensity of 0.09 mj/mm2, 300 shocks/site). One-month after end of treatment the same baseline assessment was repeated. An active PDE5i medication regime was then provided and final erectile function was reassessed. Main endpoints for success were changes in RS and in the International Index of Erectile Function (IIEF-ED) Domain score. This study further emphasises the need to study specific populations with unique etiologies causing ED.

Enrollment: 20 estimated patients

Sex: Male

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Post Radical prostatectomy
• ED of more than 6 months
• Rigidity score ≤ 2 during PDE5i therapy
• Stable heterosexual relationship for more than 3 months
• Patients need to know and to agree that the study protocol does not allow any PDE5I therapy till week 13 .

Exclusion criteria

• Prior surgery or radiotherapy in pelvic region
• Any unstable, psychiatric, spinal cord injury and penile anatomical abnormalities
• Clinically significant chronic hematological disease
• Anti-androgens, oral or injectable androgens
• Cardiovascular conditions that prevent sexual activity

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

LI-ESWT

Experimental group

Description:

Low intensity shock wave treatment- 12 sessions

Treatment:

Device: LI-ESWT